Healthcare Innovator With A Potential 17% Upside
Pacific Biosciences of California, Inc. (NASDAQ: PACB), an innovator in the healthcare sector, is carving a niche in the medical devices industry with its unique sequencing solutions. Despite the company’s current challenges, investors are intrigued by its potential, as evidenced by the 17.53% upside projected by analysts.
Pacific Biosciences, headquartered in Menlo Park, California, specializes in designing and manufacturing sequencing systems that address genetically complex problems. Their product lineup, including the Revio, Vega, Sequel, and Sequel II instruments, is renowned for conducting, monitoring, and analyzing single-molecule biochemical reactions in real time. These systems are pivotal in various sectors, from…
